Neuraminidase inhibitors are effective and safe in reducing influenza complications: meta-analysis of randomized controlled trials.
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 86, 54-65
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Early Oseltamivir Treatment of Influenza in Children 1–3 Years of Age: A Randomized Controlled TrialClinical Infectious Diseases, 2010
- Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trialsJournal of Antimicrobial Chemotherapy, 2010
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ, 2009
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in SpainCritical Care, 2009
- A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese populationCurrent Medical Research and Opinion, 2005
- Zanamivir: a Significant Reduction in Viral Load During Treatment in Military Conscripts with InfluenzaScandinavian Journal of Infectious Diseases, 2003
- Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European StudyJournal of Infection, 2000
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997